A Randomized, Controlled, Pilot Trial to Assess the Effects of a Proprietary Nutritional Supplement on Nicotinamide Adenine Dinucleotide (NAD+) Responses in Healthy Adults
Shaklee Corporation
Summary
The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.
Description
The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+), its metabolites, and markers of health in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.
Eligibility
- Age range
- 45–65 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: 1. Males and females, ≥45 to ≤65 years of age 2. BMI ≥18.5 and \<30.0 kg/m2 3. Ambulatory and currently free of injury or other physical impairment that hinders mobility. 4. Willing to use personal smart phone with operating system (Android version 12.0 or newer; iOS version 16 or newer). 5. Willingness to maintain current skin care regimen and avoid any skin-related medical procedures. 6. Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study and authorization to release relevant…
Interventions
- Dietary SupplementProprietary Nutritional Supplement
1000 mg nicotinamide metabolites and plant extracts, taken orally, daily for 60 days
- Dietary SupplementPlacebo Supplement
1000 mg maltodextrin, taken orally, daily for 60 days
Location
- Biofortis Clinical ResearchAddison, Illinois